血小板在与瘤相关的巨细胞的代谢重编程中的作用
Ying Kang1, Emmanuel Boadi Amoafo1, Philomena Entsie1
1Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, ND, United States.
Frontiers in physiology
|September 11, 2023
概括
癌细胞在瘤微环境 (TME) 中逃避免疫监测. 针对TME中的血小板-巨相互作用提供了一种新的策略,可以重编程免疫抑制性瘤相关巨细胞 (TAM) 并抑制癌症生长.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 癌症发病率和死亡率在全球范围内不断增加,需要新的治疗策略.
- 瘤细胞创造了一个免疫抑制的瘤微环境 (TME),以逃避免疫监测.
- 巨细胞在TME内分化为瘤相关巨细胞 (TAMs),通过免疫抑制促进瘤生长.
研究的目的:
- 审查TME中血小板和巨细胞之间的相互作用.
- 探索将TAM重编程为抗瘤表型的策略.
- 突出针对癌症中血小板-巨细胞通信的治疗潜力.
主要方法:
- 文献综述专注于TME中的血小板-巨细胞相互作用.
- 对血小板影响TAM表型和功能的机制的分析.
- 讨论针对血小板-巨细胞信号通路的治疗干预措施.
主要成果:
- 血小板有助于TME内的癌症生长和免疫抑制.
- 通过分泌的介质和细胞与细胞接触的血小板-巨细胞通信,塑造了TAM生物学.
- 通过调节血小板相互作用来重新编程TAM是一种潜在的抗癌策略.
结论:
- 血小板-巨细胞相互作用是TME的关键调节者.
- 针对这些相互作用为开发新型癌症免疫疗法提供了一个有希望的途径.
- 通过血小板调节重新编程TAM可以抑制瘤的进展.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.6K
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
28.1K
相关概念视频
Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
Formation of the Platelet Plug
6.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.6K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Inflammation
53.8K
Overview
53.8K
